About the Company - Alpa Laboratories Ltd
Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 112.27 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2022.
| Management |
|---|
| Name | Position Held |
|---|
| Mr. Mahendra Singh Chawla | Chairman |
| Mr. Paresh Chawla | Managing Director |
| Mr. Devendra Baheti | Independent Director |
| Mr. Sharad Chand Lunawat | Independent Director |
| Mr. Krishna Das Malani | Independent Director |
| Mrs. Jyoti Jain | Independent Director |
| Mr. Pravin Shah | Director |
Alpa Laboratories Ltd. Share Price Update |
|---|
| Share Price | Value |
|---|
| Today | ₹96.34 |
| Previous Day | ₹98.06 |
Basic Stock Data of Alpa Laboratories Ltd
| Market Cap | 206 Cr. |
|---|
| Current Price | 97.8 |
|---|
| High / Low | 107/50.1 |
|---|
| Stock P/E | 11.1 |
|---|
| Book Value | 72.9 |
|---|
| Dividend Yield | 0.00 % |
|---|
| ROCE | 8.99 % |
|---|
| ROE | 7.26 % |
|---|
| Face Value | 10.0 |
|---|
Alpa Laboratories Ltd Quarterly Results
| Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|
| Sales | 23.11 | 33.16 | 24.99 | 31.52 | 26.26 | 29.33 | 25.50 | 22.42 | 13.54 | 27.31 | 29.16 | 25.43 | 32.39 |
| Expenses | 21.37 | 30.23 | 23.76 | 28.98 | 22.73 | 25.61 | 26.86 | 21.00 | 19.28 | 24.68 | 19.90 | 26.58 | 29.07 |
| Operating Profit | 1.74 | 2.93 | 1.23 | 2.54 | 3.53 | 3.72 | -1.36 | 1.42 | -5.74 | 2.63 | 9.26 | -1.15 | 3.32 |
| OPM % | 7.53% | 8.84% | 4.92% | 8.06% | 13.44% | 12.68% | -5.33% | 6.33% | -42.39% | 9.63% | 31.76% | -4.52% | 10.25% |
| Other Income | 0.87 | 1.18 | 0.64 | 4.26 | 2.70 | 2.20 | 3.72 | 1.61 | 6.38 | 2.69 | -0.76 | 4.47 | 2.95 |
| Interest | 0.03 | 0.03 | 0.02 | 0.04 | 0.06 | 0.08 | 0.07 | 0.03 | 0.08 | 0.07 | 0.04 | 0.02 | 0.04 |
| Depreciation | 0.29 | 0.31 | 0.35 | 0.31 | 0.42 | 0.43 | 0.50 | 0.34 | 0.36 | 0.10 | 0.53 | 0.28 | 0.49 |
| Profit before tax | 2.29 | 3.77 | 1.50 | 6.45 | 5.75 | 5.41 | 1.79 | 2.66 | 0.20 | 5.15 | 7.93 | 3.02 | 5.74 |
| Tax % | -0.00% | -0.00% | 235.33% | -0.00% | -0.00% | -0.00% | 304.47% | -0.00% | -0.00% | -0.00% | 41.74% | -0.00% | -0.00% |
| Net Profit | 2.29 | 3.77 | -2.03 | 6.45 | 5.75 | 5.41 | -3.66 | 2.66 | 0.20 | 5.14 | 4.62 | 3.03 | 5.74 |
| EPS in Rs | 1.09 | 1.79 | -0.96 | 3.07 | 2.73 | 2.57 | -1.74 | 1.26 | 0.10 | 2.44 | 2.20 | 1.44 | 2.73 |
Alpa Laboratories Ltd Quarterly Chart
Alpa Laboratories Ltd Profit & Loss
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|
| Sales | 55 | 56 | 56 | 57 | 53 | 63 | 62 | 77 | 85 | 97 | 112 | 93 | 114 |
| Expenses | 53 | 53 | 51 | 54 | 47 | 56 | 57 | 76 | 79 | 90 | 101 | 85 | 100 |
| Operating Profit | 3 | 3 | 6 | 3 | 7 | 7 | 4 | 1 | 6 | 8 | 11 | 8 | 14 |
| OPM % | 5% | 5% | 10% | 6% | 13% | 11% | 7% | 2% | 7% | 8% | 10% | 9% | 12% |
| Other Income | 1 | 0 | 1 | 2 | 6 | 4 | 5 | 5 | 0 | 4 | 11 | 9 | 9 |
| Interest | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 5 | 9 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Profit before tax | 1 | -3 | -5 | -3 | 11 | 9 | 7 | 5 | 5 | 11 | 20 | 16 | 22 |
| Tax % | 37% | -36% | -4% | 48% | 27% | 34% | 27% | 36% | 20% | 33% | 28% | 21% | |
| Net Profit | 1 | -4 | -5 | -1 | 8 | 6 | 5 | 3 | 4 | 7 | 14 | 13 | 19 |
| EPS in Rs | 0.25 | -2.08 | -2.45 | -0.67 | 3.68 | 2.85 | 2.27 | 1.40 | 1.94 | 3.45 | 6.72 | 6.00 | 8.81 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
Alpa Laboratories Ltd Profit & Loss Yearly Chart
Alpa Laboratories Ltd Growth
|
| Compounded Sales Growth |
|---|
| 10 Years:: | 5% |
| 5 Years:: | 9% |
| 3 Years:: | 3% |
| TTM:: | 26% |
Alpa Laboratories Ltd Growth
|
| Compounded Profit Growth |
|---|
| 10 Years:: | 16% |
| 5 Years:: | 15% |
| 3 Years:: | 23% |
| TTM:: | 301% |
Alpa Laboratories Ltd Growth
|
| Stock Price CAGR |
|---|
| 10 Years:: | 33% |
| 5 Years:: | 33% |
| 3 Years:: | 42% |
| 1 Year:: | 87% |
Alpa Laboratories Ltd Growth
|
| Return on Equity |
|---|
| 10 Years:: | 4% |
| 5 Years:: | 5% |
| 3 Years:: | 6% |
| Last Year:: | 7% |
No data available for the Balance Sheet data table.
Alpa Laboratories Ltd Reserves and Borrowings Chart
Alpa Laboratories Ltd Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
| Cash from Operating Activity | -1 | 3 | 8 | -2 | -25 | -8 | -7 | -1 | 18 | -1 | 2 | 9 |
| Cash from Investing Activity | -1 | -4 | -2 | 37 | -7 | 1 | -16 | -15 | -11 | 6 | -16 | 2 |
| Cash from Financing Activity | 1 | 2 | 4 | 7 | -6 | -2 | 4 | -5 | -1 | -0 | 5 | -3 |
| Net Cash Flow | -1 | 0 | 10 | 42 | -37 | -9 | -19 | -20 | 5 | 4 | -8 | 7 |
|
Alpa Laboratories Ltd Financial Efficiency Indicators
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
| Debtor Days | 142 | 127 | 130 | 156 | 234 | 169 | 151 | 141 | 105 | 133 | 124 | 184 |
| Inventory Days | 142 | 132 | 148 | 76 | 196 | 131 | 140 | 105 | 90 | 102 | 81 | 84 |
| Days Payable | 142 | 85 | 121 | 91 | 244 | 140 | 130 | 99 | 98 | 152 | 78 | 100 |
| Cash Conversion Cycle | 142 | 174 | 157 | 141 | 187 | 160 | 161 | 148 | 97 | 83 | 127 | 168 |
| Working Capital Days | 265 | 187 | 169 | 178 | 390 | 256 | 234 | 194 | 121 | 137 | 136 | 155 |
| ROCE % | 2% | -1% | -3% | 0% | 10% | 11% | 7% | 4% | 7% | 7% | 9% | 9% |
Alpa Laboratories Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Alpa Laboratories Ltd Shareholding Pattern Chart
No. of Alpa Laboratories Ltd Shareholders
This stock is not held by any mutual fund
Alpa Laboratories Ltd ROCE Trend
Alpa Laboratories Ltd EPS Trend
Alpa Laboratories Ltd Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.90 | 6.70 | 3.44 | 0.88 | 0.37 |
| Diluted EPS (Rs.) | 5.90 | 6.70 | 3.44 | 0.89 | 0.37 |
| Cash EPS (Rs.) | 6.63 | 7.48 | 4.03 | 2.38 | 1.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.96 | 57.85 | 51.16 | 47.70 | 46.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.96 | 57.85 | 51.16 | 47.70 | 46.71 |
| Revenue From Operations / Share (Rs.) | 43.93 | 53.36 | 46.36 | 40.86 | 37.06 |
| PBDIT / Share (Rs.) | 8.31 | 10.19 | 5.75 | 2.98 | 2.96 |
| PBIT / Share (Rs.) | 7.68 | 9.40 | 5.16 | 1.48 | 1.48 |
| PBT / Share (Rs.) | 7.58 | 9.30 | 5.13 | 1.38 | 1.21 |
| Net Profit / Share (Rs.) | 6.00 | 6.70 | 3.44 | 0.88 | 0.37 |
| NP After MI And SOA / Share (Rs.) | 6.00 | 6.70 | 3.44 | 0.88 | 0.37 |
| PBDIT Margin (%) | 18.91 | 19.09 | 12.39 | 7.29 | 7.98 |
| PBIT Margin (%) | 17.48 | 17.61 | 11.13 | 3.61 | 3.98 |
| PBT Margin (%) | 17.24 | 17.42 | 11.05 | 3.38 | 3.25 |
| Net Profit Margin (%) | 13.66 | 12.55 | 7.42 | 2.15 | 1.01 |
| NP After MI And SOA Margin (%) | 13.66 | 12.55 | 7.42 | 2.15 | 1.01 |
| Return on Networth / Equity (%) | 9.38 | 11.57 | 6.73 | 1.84 | 0.80 |
| Return on Capital Employeed (%) | 11.80 | 15.97 | 10.07 | 3.08 | 3.14 |
| Return On Assets (%) | 7.54 | 9.07 | 5.16 | 1.52 | 0.65 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.01 | 0.04 | 0.00 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 0.55 | 0.73 | 0.71 | 0.68 | 0.62 |
| Current Ratio (X) | 4.98 | 4.43 | 3.73 | 4.59 | 4.22 |
| Quick Ratio (X) | 4.56 | 3.93 | 3.22 | 3.99 | 3.59 |
| Inventory Turnover Ratio (X) | 3.89 | 3.96 | 3.73 | 3.72 | 3.35 |
| Interest Coverage Ratio (%) | 78.28 | 97.84 | 155.24 | 31.95 | 10.95 |
| Interest Coverage Ratio (Post Tax) (%) | 57.55 | 65.32 | 94.03 | 10.45 | 2.40 |
| Enterprise Value (Cr.) | 105.31 | 149.57 | 65.56 | 23.69 | 56.32 |
| EV / Net Operating Revenue (X) | 1.14 | 1.33 | 0.67 | 0.27 | 0.72 |
| EV / EBITDA (X) | 6.02 | 6.98 | 5.42 | 3.78 | 9.05 |
| MarketCap / Net Operating Revenue (X) | 1.22 | 1.30 | 0.77 | 0.34 | 0.71 |
| Price / BV (X) | 0.84 | 1.20 | 0.70 | 0.29 | 0.56 |
| Price / Net Operating Revenue (X) | 1.22 | 1.30 | 0.77 | 0.34 | 0.71 |
| EarningsYield | 0.11 | 0.09 | 0.09 | 0.06 | 0.01 |
Alpa Laboratories Ltd Profitability Ratios (%)
Alpa Laboratories Ltd Liquidity Ratios
Alpa Laboratories Ltd Liquidity Ratios (%)
Alpa Laboratories Ltd Interest Coverage Ratios (%)
Alpa Laboratories Ltd Valuation Ratios
Strength and Weakness of Alpa Laboratories Ltd Stock
Unable to fetch valid data for stock valuation.
